相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST) : a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Benjamin A. Fisher et al.
LANCET RESPIRATORY MEDICINE (2022)
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
Zelalem Temesgen et al.
LANCET RESPIRATORY MEDICINE (2022)
Preliminary predictive criteria for COVID-19 cytokine storm
Roberto Caricchio et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype
Hui Chen et al.
CHEST (2021)
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
Ryan S. Thwaites et al.
SCIENCE IMMUNOLOGY (2021)
The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?
Michael A. Matthay et al.
LANCET RESPIRATORY MEDICINE (2021)
MAVRILIMUMAB IMPROVES OUTCOMES IN PHASE 2 TRIAL IN NON-MECHANICALLY-VENTILATED PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION
L. Pupim et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 A Randomized Clinical Trial
Roberto Caricchio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis
Manu Shankar-Hari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019
Sylvia Ranjeva et al.
ECLINICALMEDICINE (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Yonggang Zhou et al.
NATIONAL SCIENCE REVIEW (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
Puja Mehta et al.
LANCET RESPIRATORY MEDICINE (2020)
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
Aldo Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2020)
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study
Zelalem Temesgen et al.
MAYO CLINIC PROCEEDINGS (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
Frederick M. Lang et al.
NATURE REVIEWS IMMUNOLOGY (2020)
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
Giacomo De Luca et al.
LANCET RHEUMATOLOGY (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Neutrophil GM-CSF receptor dynamics in acute lung injury
Silvia De Alessandris et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Rosalie M. Sterner et al.
BLOOD (2019)
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
Carolyn S. Calfee et al.
LANCET RESPIRATORY MEDICINE (2018)
Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study
Pratik Sinha et al.
INTENSIVE CARE MEDICINE (2018)
Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells
Sonia Tugues et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
High-Flow Oxygen, Positive End-Expiratory Pressure, and the Berlin Definition of Acute Respiratory Distress Syndrome: Are They Mutually Exclusive?
Jason Chertoff
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Nonlinear Imputation of Pao2/Fio2 From Spo2/Fio2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study
Samuel M. Brown et al.
CRITICAL CARE MEDICINE (2017)
Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Patients With Acute Respiratory Distress Syndrome
Samuel M. Brown et al.
CHEST (2016)
Acute Respiratory Distress Syndrome The Berlin Definition
V. Marco Ranieri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
GM-CSF Signalling Boosts Dramatically IL-1Production
Hanif Javanmard Khameneh et al.
PLOS ONE (2011)
Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF
Ruzica Pujic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
分享论文
